
PRQR
Healthcare · Biotechnology · $199.3M market cap
$1.42+0.06 (+4.4%)Nov 13, 4:00 PM EST
Next report
Time not confirmed
Analyst consensus
Fiscal period ending Sep 30, 2026
EPS trend, 90 days to now · +22.6% over 90 days · 30-day revisions 1 up, 0 down
Beat estimates in 3 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 19, 2026 · upcoming | Time not confirmed | -0.11 | -0.10 | +6.1% |
| Aug 20, 2026 | Time not confirmed | -0.14 | -0.10 | +28.6% |
| May 12, 2026 | Before the open | -0.18 | -0.15 | +16.7% |
| Feb 19, 2026 | Time not confirmed | -0.09 | -0.09 | -4.6% |
| Nov 6, 2025 | Before the open | -0.17 | -0.12 | +29.4% |
| Aug 7, 2025 | Before the open | -0.08 | -0.14 | -75.0% |
| May 8, 2025 | Before the open | -0.16 | -0.11 | +31.3% |
| Mar 13, 2025 | Time not confirmed | -0.09 | -0.09 | +4.9% |
| Nov 7, 2024 | Before the open | -0.14 | -0.08 | +42.9% |
| Aug 8, 2024 | Before the open | -0.17 | -0.04 | +76.5% |
| May 9, 2024 | Before the open | -0.16 | -0.10 | +37.5% |
| Mar 13, 2024 | Before the open | 0.01 | -0.07 | -800.0% |
| Nov 7, 2023 | Before the open | -0.13 |
ProQR Therapeutics N.V., a clinical-stage biotechnology company, focuses on the discovery and development of novel therapeutic medicines. The company develops an RNA editing platform through its Axiomer RNA editing technology for genetic disorders with unmet needs. Its lead product candidate, AX-0810, targets na-taurocholate cotransporting polypeptide (NTCP) for the treatment of cholestatic diseases. The company…
| -0.08 |
| +38.5% |
| Aug 3, 2023 | Before the open | -0.12 | -0.11 | +8.3% |
| May 16, 2023 | Before the open | -0.10 | -0.13 | -30.0% |
| Mar 29, 2023 | After the close | -0.16 | -0.16 | 0.0% |
| Nov 9, 2022 | Before the open | -0.23 | -0.29 | -26.1% |
| Aug 4, 2022 | Before the open | -0.22 | -0.23 | -4.5% |
| May 5, 2022 | After the close | -0.24 | -0.20 | +16.7% |
| Feb 24, 2022 | Before the open | -0.12 | -0.28 | -133.3% |
| Nov 4, 2021 | Before the open | -0.24 | -0.24 | 0.0% |
| Aug 5, 2021 | Before the open | -0.27 | -0.28 | -3.7% |
| May 6, 2021 | Before the open | -0.30 | -0.30 | 0.0% |
| Feb 25, 2021 | Before the open | -0.25 | -0.26 | -4.0% |
| Nov 16, 2020 | Before the open | -0.39 | -0.31 | +20.5% |
| Aug 6, 2020 | After the close | -0.35 | -0.09 | +74.3% |
| May 7, 2020 | Before the open | -0.36 | -0.35 | +2.8% |
| Feb 26, 2020 | Before the open | -0.35 | -0.39 | -11.4% |
| Nov 6, 2019 | Before the open | -0.38 | -0.34 | +10.5% |
| Aug 7, 2019 | Before the open | -0.43 | -0.34 | +20.9% |
| May 8, 2019 | Before the open | -0.38 | -0.40 | -5.3% |
| Feb 27, 2019 | Before the open | -0.26 | -0.38 | -46.2% |
| Nov 7, 2018 | Before the open | -0.31 | -0.21 | +32.3% |
| Aug 8, 2018 | Before the open | -0.47 | -0.27 | +42.6% |
| May 9, 2018 | Before the open | -0.40 | -0.40 | 0.0% |
| Feb 28, 2018 | Before the open | -0.48 | -0.46 | +4.2% |